Charles River Laboratories (NYSE:CRL) is a global provider of essential products and services that accelerate drug discovery and development processes. It is traded solely on the New York Stock Exchange under the ticker (NYSE:CRL). The company specializes in a broad range of solutions including laboratory animal models, critical testing services for endotoxin and microbial detection, and a suite of CRO (Contract Research Organization) services. Charles River Laboratories focuses on enabling its clients in the pharmaceutical, biotechnology, and medical device industries to bring their products to market faster and more efficiently. Its objectives revolve around innovation in life sciences to enhance the quality and speed of research, with an emphasis on ensuring both efficacy and safety in novel therapeutics and diagnostics being developed for human health.